. . . "investigational"@en . . "36322-90-4"@en . . . . . . . . . . . . "Piroxicamum"@en . . . . . "4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid"@en . . "A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily. [PubChem]"@en . . . . . . . . . . . . . . "Pyroxycam"@en . . "Paul D. Weeks, \"3-Hydroxy 2-methyl benzisothiazolines as intermediates in production of piroxicam.\" U.S. Patent US4376204, issued April, 1982."@en . "* 0.14 L/kg"@en . . "Piroxicam"@en . . "The antiinflammatory effect of Piroxicam may result from the reversible inhibition of cyclooxygenase, causing the peripheral inhibition of prostaglandin synthesis. The prostaglandins are produced by an enzyme called Cox-1. Piroxicam blocks the Cox-1 enzyme, resulting into the disruption of production of prostaglandins. Piroxicam also inhibits the migration of leukocytes into sites of inflammation and prevents the formation of thromboxane A2, an aggregating agent, by the platelets."@en . . . . . "Feldene"@en . . . . "30 to 86 hours"@en . . . " "@en . . . . . . "approved"@en . . . . . . . . . . . . . "Piroxicam and its biotransformation products are excreted in urine and feces, with about twice as much appearing in the urine as in the feces. Approximately 5% of a piroxicam dose is excreted unchanged. However, a substantial portion of piroxicam elimination occurs by hepatic metabolism. Piroxicam is excreted into human milk."@en . . "Well absorbed following oral administration."@en . . . . . . . . . . . . . . . . . . . . . . . . . . . "Symptoms of overdose include drowsiness, nausea, stomach pain, and/or vomiting."@en . . . . . . . . . . . . . . . . . . . . . "For treatment of osteoarthritis and rheumatoid arthritis."@en . . . . . . . . . "Piroxicam"@en . . "Humans and other mammals"@en . . . . . . . . . . . . "Take with food. Avoid alcohol."@en .